LUMIFY Redness Reliever Eye Drops
NDC 24208-537, BRIMONIDINE TARTRATE, solution/ drops, from Bausch & Lomb Incorporated.
- Product NDC
- 24208-537
- Status
- Listed
- Labeler
- Bausch & Lomb Incorporated
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA208144
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24208-537 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIMONIDINE TARTRATE.25 mg/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24208-537-01 | 24208053701 | 1 AMPULE in 1 CARTON (24208-537-01) / .4 mL in 1 AMPULE |
| 24208-537-05 | 24208053705 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-05) / 5 mL in 1 BOTTLE, DROPPER |
| 24208-537-08 | 24208053708 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-08) / 2.5 mL in 1 BOTTLE, DROPPER |
| 24208-537-10 | 24208053710 | 1 AMPULE in 1 CARTON (24208-537-10) / .4 mL in 1 AMPULE |
| 24208-537-15 | 24208053715 | 2 BOTTLE, DROPPER in 1 CARTON (24208-537-15) / 7.5 mL in 1 BOTTLE, DROPPER |
| 24208-537-25 | 24208053725 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-25) / 7.5 mL in 1 BOTTLE, DROPPER |
| 24208-537-35 | 24208053735 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-35) / 3.5 mL in 1 BOTTLE, DROPPER |
| 24208-537-75 | 24208053775 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-75) / 7.5 mL in 1 BOTTLE, DROPPER |
| 24208-537-99 | 24208053799 | 1 BOTTLE, DROPPER in 1 CARTON (24208-537-99) / 2.5 mL in 1 BOTTLE, DROPPER |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 24208053708
GET /v1/drugs/nadac/24208053708NADAC price for package 24208053725
GET /v1/drugs/nadac/24208053725
Use it
Look up 24208-537 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24208-537 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24208-537. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.